Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Colucci

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
The Breast Journal|May 22, 2020
A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?Mariangela Ciccarese, Laura Orlando, Palma Fedele, et al.
The Lancet. Haematology|July 2, 2022
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trialStefano Barco, Davide Voci, Ulrike Held, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2023
Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European StudyFilippo Biscarini, Giulia Masetti, Ilaria Muller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alphaPaolo Pedrazzoli, Antonio Farris, Salvatore Del Prete, et al.
BMC Cancer|January 10, 2006
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective studySandro Pignata, Sabino De Placido, Rosalbino Biamonte, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2023
Externalized histones fuel pulmonary fibrosis via a platelet-macrophage circuit of TGFβ1 and IL-27Dennis R Riehl, Arjun Sharma, Julian Roewe, et al.
Thrombosis Research|November 17, 2022
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trialDavide Voci, Andrea Götschi, Ulrike Held, et al.
Journal of Clinical Medicine|May 11, 2024
Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum HemorrhageCamila Caram-Deelder, Hellen McKinnon Edwards, Jarmila A Zdanowicz, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
Stop Flow in abdominal and pelvic cancer relapsesRosario Vincenzo Iaffaioli, Gaetano Facchini, Anna Tortoriello, et al.
Oncotarget|November 8, 2017
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO studyMaurizio Muscaritoli, Simone Lucia, Alessio Farcomeni, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
The Breast Journal|May 22, 2020
A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?Mariangela Ciccarese, Laura Orlando, Palma Fedele, et al.
The Lancet. Haematology|July 2, 2022
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trialStefano Barco, Davide Voci, Ulrike Held, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2023
Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European StudyFilippo Biscarini, Giulia Masetti, Ilaria Muller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alphaPaolo Pedrazzoli, Antonio Farris, Salvatore Del Prete, et al.
BMC Cancer|January 10, 2006
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective studySandro Pignata, Sabino De Placido, Rosalbino Biamonte, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2023
Externalized histones fuel pulmonary fibrosis via a platelet-macrophage circuit of TGFβ1 and IL-27Dennis R Riehl, Arjun Sharma, Julian Roewe, et al.
Thrombosis Research|November 17, 2022
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trialDavide Voci, Andrea Götschi, Ulrike Held, et al.
Journal of Clinical Medicine|May 11, 2024
Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum HemorrhageCamila Caram-Deelder, Hellen McKinnon Edwards, Jarmila A Zdanowicz, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
Stop Flow in abdominal and pelvic cancer relapsesRosario Vincenzo Iaffaioli, Gaetano Facchini, Anna Tortoriello, et al.
Oncotarget|November 8, 2017
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO studyMaurizio Muscaritoli, Simone Lucia, Alessio Farcomeni, et al.
Pageof 14